# Newmont timeline

entity: /record/newmont.md  
id: ent_newmont  

Newmont's timeline holds 507 claims from 2002 to 2026: 3 people, 489 money & deals, 15 other. 12 are undated. The latest took effect on October 15, 2026.

Kinds: People 3 (/timelines/newmont.md?kind=people) · Money & deals 489 (/timelines/newmont.md?kind=money) · Products 0 (/timelines/newmont.md?kind=products) · Models 0 (/timelines/newmont.md?kind=models) · Other 15 (/timelines/newmont.md?kind=other)  
Format: date | kind | predicate | value | status | claim.

## 2002

- 2002-02-15 to 2002-03-12 | other | registrant_name | DELTA HOLDCO CORP | superseded | [clm_1115631DE712](/claim/clm_1115631DE712.md)
- 2002-03-12 to 2019-04-16 | other | registrant_name | NEWMONT MINING CORP /DE/ | superseded | [clm_F6D5E56F355B](/claim/clm_F6D5E56F355B.md)

## 2006

- 2006-12-31 to 2007-12-31 | money | cash_and_equivalents | 1,163,000,000 United States dollar | superseded | [clm_7E75A3D6720A](/claim/clm_7E75A3D6720A.md)
- 2006-12-31 to 2007-12-31 | money | total_equity | 10,435,000,000 United States dollar | superseded | [clm_825AFA251334](/claim/clm_825AFA251334.md)

## 2007

- 2007-12-31 to 2008-03-31 | money | cash_and_equivalents | 1,230,000,000 United States dollar | superseded | [clm_1135CF00AEDC](/claim/clm_1135CF00AEDC.md)
- 2007-12-31 to 2008-12-31 | money | net_income | -1,895,000,000 United States dollar | superseded | [clm_C43D0C4DD9DF](/claim/clm_C43D0C4DD9DF.md)
- 2007-12-31 to 2008-12-31 | money | research_and_development | 62,000,000 United States dollar | superseded | [clm_5E682198FD9E](/claim/clm_5E682198FD9E.md)
- 2007-12-31 to 2008-12-31 | money | total_equity | 9,208,000,000 United States dollar | superseded | [clm_F5391B6A0F4B](/claim/clm_F5391B6A0F4B.md)

## 2008

- 2008-03-31 to 2008-06-30 | money | cash_and_equivalents | 1,014,000,000 United States dollar | superseded | [clm_26DE8F75ECD8](/claim/clm_26DE8F75ECD8.md)
- 2008-03-31 to 2008-06-30 | money | quarterly_net_income | 365,000,000 United States dollar | superseded | [clm_888FECC45E41](/claim/clm_888FECC45E41.md)
- 2008-03-31 to 2008-06-30 | money | quarterly_research_and_development | 30,000,000 United States dollar | superseded | [clm_D4B6E5EEC956](/claim/clm_D4B6E5EEC956.md)
- 2008-06-30 to 2008-09-30 | money | cash_and_equivalents | 1,036,000,000 United States dollar | superseded | [clm_BF776166E5FD](/claim/clm_BF776166E5FD.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_net_income | 271,000,000 United States dollar | superseded | [clm_6E846B4BD48B](/claim/clm_6E846B4BD48B.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_research_and_development | 39,000,000 United States dollar | superseded | [clm_DDC7EF09486A](/claim/clm_DDC7EF09486A.md)
- 2008-09-30 to 2008-12-31 | money | cash_and_equivalents | 853,000,000 United States dollar | superseded | [clm_579177700465](/claim/clm_579177700465.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_net_income | 191,000,000 United States dollar | superseded | [clm_049BB0854E31](/claim/clm_049BB0854E31.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_research_and_development | 44,000,000 United States dollar | superseded | [clm_082494421026](/claim/clm_082494421026.md)
- 2008-12-31 to 2009-03-31 | money | cash_and_equivalents | 435,000,000 United States dollar | superseded | [clm_FA087FAEC36D](/claim/clm_FA087FAEC36D.md)
- 2008-12-31 to 2009-12-31 | money | net_income | 831,000,000 United States dollar | superseded | [clm_0C48D0FDE233](/claim/clm_0C48D0FDE233.md)
- 2008-12-31 to 2009-12-31 | money | research_and_development | 166,000,000 United States dollar | superseded | [clm_477AF77867A9](/claim/clm_477AF77867A9.md)
- 2008-12-31 to 2009-03-31 | money | total_assets | 15,727,000,000 United States dollar | superseded | [clm_F6ADED20A4EA](/claim/clm_F6ADED20A4EA.md)
- 2008-12-31 to 2009-03-31 | money | total_equity | 7,291,000,000 United States dollar | superseded | [clm_D2F1F8F25617](/claim/clm_D2F1F8F25617.md)

## 2009

- 2009-03-31 to 2009-06-30 | money | cash_and_equivalents | 1,451,000,000 United States dollar | superseded | [clm_D1F0EA5959DA](/claim/clm_D1F0EA5959DA.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_net_income | 189,000,000 United States dollar | superseded | [clm_E2FCA87481D4](/claim/clm_E2FCA87481D4.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_research_and_development | 31,000,000 United States dollar | superseded | [clm_CA95493D5D8E](/claim/clm_CA95493D5D8E.md)
- 2009-03-31 to 2009-06-30 | money | total_assets | 17,025,000,000 United States dollar | superseded | [clm_7992420B363E](/claim/clm_7992420B363E.md)
- 2009-03-31 to 2009-06-30 | money | total_equity | 8,771,000,000 United States dollar | superseded | [clm_9C3800D8F3D3](/claim/clm_9C3800D8F3D3.md)
- 2009-04-22 to 2009-07-15 | money | shares_outstanding | 478,974,794 shares | superseded | [clm_FEDFE296DB77](/claim/clm_FEDFE296DB77.md)
- 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 544,000,000 United States dollar | superseded | [clm_B94A19A9075E](/claim/clm_B94A19A9075E.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_net_income | 162,000,000 United States dollar | superseded | [clm_DEC3CC643C85](/claim/clm_DEC3CC643C85.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_research_and_development | 42,000,000 United States dollar | superseded | [clm_1585F522319F](/claim/clm_1585F522319F.md)
- 2009-06-30 to 2009-09-30 | money | total_assets | 18,111,000,000 United States dollar | superseded | [clm_0780EDE58F2E](/claim/clm_0780EDE58F2E.md)
- 2009-06-30 to 2009-09-30 | money | total_equity | 9,263,000,000 United States dollar | superseded | [clm_2F1A55160E16](/claim/clm_2F1A55160E16.md)
- 2009-07-15 to 2009-10-23 | money | shares_outstanding | 479,717,438 shares | superseded | [clm_7AA48D59B2E3](/claim/clm_7AA48D59B2E3.md)
- 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 3,022,000,000 United States dollar | superseded | [clm_6794E4C3459B](/claim/clm_6794E4C3459B.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_net_income | 388,000,000 United States dollar | superseded | [clm_2068EF29ADBA](/claim/clm_2068EF29ADBA.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_research_and_development | 27,000,000 United States dollar | superseded | [clm_0D21116114C2](/claim/clm_0D21116114C2.md)
- 2009-09-30 to 2009-12-31 | money | total_assets | 21,147,000,000 United States dollar | superseded | [clm_82AE40213633](/claim/clm_82AE40213633.md)
- 2009-09-30 to 2009-12-31 | money | total_equity | 9,923,000,000 United States dollar | superseded | [clm_E7770D55ECCD](/claim/clm_E7770D55ECCD.md)
- 2009-10-23 to 2010-02-17 | money | shares_outstanding | 480,405,625 shares | superseded | [clm_F3E22FD7E744](/claim/clm_F3E22FD7E744.md)
- 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 3,215,000,000 United States dollar | superseded | [clm_FB5AA73CB948](/claim/clm_FB5AA73CB948.md)
- 2009-12-31 to 2010-12-31 | money | net_income | 1,297,000,000 United States dollar | superseded | [clm_A51AC704317E](/claim/clm_A51AC704317E.md)
- 2009-12-31 to 2010-12-31 | money | research_and_development | 135,000,000 United States dollar | superseded | [clm_A7F88DF02E22](/claim/clm_A7F88DF02E22.md)
- 2009-12-31 to 2010-03-31 | money | total_assets | 22,299,000,000 United States dollar | superseded | [clm_4A8A468CCD29](/claim/clm_4A8A468CCD29.md)
- 2009-12-31 to 2010-03-31 | money | total_equity | 10,703,000,000 United States dollar | superseded | [clm_1BEF2B74F2E2](/claim/clm_1BEF2B74F2E2.md)

## 2010

- 2010-02-17 to 2010-04-20 | money | shares_outstanding | 483,029,539 shares | superseded | [clm_AF4F596A2589](/claim/clm_AF4F596A2589.md)
- 2010-03-31 to 2010-06-30 | money | cash_and_equivalents | 3,364,000,000 United States dollar | superseded | [clm_09612395AC2C](/claim/clm_09612395AC2C.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_net_income | 546,000,000 United States dollar | superseded | [clm_CD1459670519](/claim/clm_CD1459670519.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_research_and_development | 46,000,000 United States dollar | superseded | [clm_5E4654154B32](/claim/clm_5E4654154B32.md)
- 2010-03-31 to 2010-06-30 | money | total_assets | 22,645,000,000 United States dollar | superseded | [clm_DA5CC410C224](/claim/clm_DA5CC410C224.md)
- 2010-03-31 to 2010-06-30 | money | total_equity | 11,350,000,000 United States dollar | superseded | [clm_ACA54EC054FE](/claim/clm_ACA54EC054FE.md)
- 2010-04-20 to 2010-07-20 | money | shares_outstanding | 483,457,696 shares | superseded | [clm_22EA4C5D8C39](/claim/clm_22EA4C5D8C39.md)
- 2010-06-30 to 2010-09-30 | money | cash_and_equivalents | 3,602,000,000 United States dollar | superseded | [clm_B46DD57E671D](/claim/clm_B46DD57E671D.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_net_income | 382,000,000 United States dollar | superseded | [clm_FCE89C6E12B8](/claim/clm_FCE89C6E12B8.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_research_and_development | 57,000,000 United States dollar | superseded | [clm_0DE37774F05E](/claim/clm_0DE37774F05E.md)
- 2010-06-30 to 2010-09-30 | money | total_assets | 22,769,000,000 United States dollar | superseded | [clm_8B8EAC020719](/claim/clm_8B8EAC020719.md)
- 2010-06-30 to 2010-09-30 | money | total_equity | 11,515,000,000 United States dollar | superseded | [clm_103875F20DBA](/claim/clm_103875F20DBA.md)
- 2010-07-20 to 2011-02-28 | money | shares_outstanding | 484,698,098 shares | superseded | [clm_5FD53C858BB2](/claim/clm_5FD53C858BB2.md)
- 2010-09-30 to 2010-12-31 | money | cash_and_equivalents | 3,951,000,000 United States dollar | superseded | [clm_225A4FBB7E8E](/claim/clm_225A4FBB7E8E.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_net_income | 537,000,000 United States dollar | superseded | [clm_3761ADAC0724](/claim/clm_3761ADAC0724.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_research_and_development | 46,000,000 United States dollar | superseded | [clm_9E0DA76892F6](/claim/clm_9E0DA76892F6.md)
- 2010-09-30 to 2010-12-31 | money | total_assets | 24,376,000,000 United States dollar | superseded | [clm_2B11EDEC67EB](/claim/clm_2B11EDEC67EB.md)
- 2010-09-30 to 2010-12-31 | money | total_equity | 12,248,000,000 United States dollar | superseded | [clm_E8B709D92DBC](/claim/clm_E8B709D92DBC.md)
- 2010-12-31 to 2011-03-31 | money | cash_and_equivalents | 4,056,000,000 United States dollar | superseded | [clm_7171B7483CBD](/claim/clm_7171B7483CBD.md)
- 2010-12-31 to 2011-12-31 | money | net_income | 2,277,000,000 United States dollar | superseded | [clm_D6371235AC99](/claim/clm_D6371235AC99.md)
- 2010-12-31 to 2011-12-31 | money | research_and_development | 216,000,000 United States dollar | superseded | [clm_F7BE91D6469C](/claim/clm_F7BE91D6469C.md)
- 2010-12-31 to 2011-03-31 | money | total_assets | 25,663,000,000 United States dollar | superseded | [clm_D99B4E63C490](/claim/clm_D99B4E63C490.md)
- 2010-12-31 to 2011-03-31 | money | total_equity | 13,345,000,000 United States dollar | superseded | [clm_12C953CFA468](/claim/clm_12C953CFA468.md)

## 2011

- 2011-02-28 to 2011-04-12 | money | shares_outstanding | 486,564,649 shares | superseded | [clm_8976ECC49268](/claim/clm_8976ECC49268.md)
- 2011-03-31 to 2011-06-30 | money | cash_and_equivalents | 4,533,000,000 United States dollar | superseded | [clm_DDC8FF9194F6](/claim/clm_DDC8FF9194F6.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_net_income | 514,000,000 United States dollar | superseded | [clm_BF39C244BA61](/claim/clm_BF39C244BA61.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_research_and_development | 68,000,000 United States dollar | superseded | [clm_586061A56AC6](/claim/clm_586061A56AC6.md)
- 2011-03-31 to 2011-06-30 | money | total_assets | 26,854,000,000 United States dollar | superseded | [clm_6F92F5BA6741](/claim/clm_6F92F5BA6741.md)
- 2011-03-31 to 2011-06-30 | money | total_equity | 14,092,000,000 United States dollar | superseded | [clm_AB9B62760AED](/claim/clm_AB9B62760AED.md)
- 2011-04-12 to 2011-07-21 | money | shares_outstanding | 487,086,394 shares | superseded | [clm_32F21D921C82](/claim/clm_32F21D921C82.md)
- 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 1,855,000,000 United States dollar | superseded | [clm_44B0094EDEAF](/claim/clm_44B0094EDEAF.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_net_income | 387,000,000 United States dollar | superseded | [clm_20546BCF08B1](/claim/clm_20546BCF08B1.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_research_and_development | 86,000,000 United States dollar | superseded | [clm_01A600231F25](/claim/clm_01A600231F25.md)
- 2011-06-30 to 2011-09-30 | money | total_assets | 28,638,000,000 United States dollar | superseded | [clm_391747769C25](/claim/clm_391747769C25.md)
- 2011-06-30 to 2011-09-30 | money | total_equity | 14,328,000,000 United States dollar | superseded | [clm_F36CC1D4017F](/claim/clm_F36CC1D4017F.md)
- 2011-07-21 to 2011-10-20 | money | shares_outstanding | 487,574,675 shares | superseded | [clm_0F1461C93DF4](/claim/clm_0F1461C93DF4.md)
- 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 2,135,000,000 United States dollar | superseded | [clm_732F7BADBD1B](/claim/clm_732F7BADBD1B.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_net_income | 493,000,000 United States dollar | superseded | [clm_55440FA4D6FE](/claim/clm_55440FA4D6FE.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_research_and_development | 93,000,000 United States dollar | superseded | [clm_BBC2A083C499](/claim/clm_BBC2A083C499.md)
- 2011-09-30 to 2011-12-31 | money | total_assets | 29,139,000,000 United States dollar | superseded | [clm_F7884FCDD04F](/claim/clm_F7884FCDD04F.md)
- 2011-09-30 to 2011-12-31 | money | total_equity | 13,860,000,000 United States dollar | superseded | [clm_43AF1382869F](/claim/clm_43AF1382869F.md)
- 2011-10-20 to 2012-01-31 | money | shares_outstanding | 488,214,270 shares | superseded | [clm_409916A7A270](/claim/clm_409916A7A270.md)
- 2011-12-15 | other | x_username | NewmontCorp | unverified | [clm_2A35943D4EDE](/claim/clm_2A35943D4EDE.md)
- 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 1,760,000,000 United States dollar | superseded | [clm_6EB87C399E65](/claim/clm_6EB87C399E65.md)
- 2011-12-31 to 2012-12-31 | money | net_income | 366,000,000 United States dollar | superseded | [clm_523975D25F77](/claim/clm_523975D25F77.md)
- 2011-12-31 to 2012-12-31 | money | research_and_development | 373,000,000 United States dollar | superseded | [clm_83E3495DB884](/claim/clm_83E3495DB884.md)
- 2011-12-31 to 2012-03-31 | money | total_assets | 27,474,000,000 United States dollar | superseded | [clm_7374F8F406C5](/claim/clm_7374F8F406C5.md)
- 2011-12-31 to 2012-03-31 | money | total_equity | 12,896,000,000 United States dollar | superseded | [clm_962F5778759C](/claim/clm_962F5778759C.md)

## 2012

- 2012-01-31 to 2012-04-18 | money | shares_outstanding | 490,150,298 shares | superseded | [clm_7F257D174ABC](/claim/clm_7F257D174ABC.md)
- 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 2,612,000,000 United States dollar | superseded | [clm_0B906D761175](/claim/clm_0B906D761175.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_net_income | 490,000,000 United States dollar | superseded | [clm_A136AD216B3C](/claim/clm_A136AD216B3C.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_research_and_development | 102,000,000 United States dollar | superseded | [clm_7C19913E5E7C](/claim/clm_7C19913E5E7C.md)
- 2012-03-31 to 2012-06-30 | money | total_assets | 28,961,000,000 United States dollar | superseded | [clm_3D33D4225694](/claim/clm_3D33D4225694.md)
- 2012-03-31 to 2012-06-30 | money | total_equity | 13,075,000,000 United States dollar | superseded | [clm_E2EE8D630C0F](/claim/clm_E2EE8D630C0F.md)
- 2012-04-18 to 2012-07-18 | money | shares_outstanding | 490,629,352 shares | superseded | [clm_F6DF60F898AA](/claim/clm_F6DF60F898AA.md)
- 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 1,897,000,000 United States dollar | superseded | [clm_8C7F03F72DB5](/claim/clm_8C7F03F72DB5.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_net_income | 279,000,000 United States dollar | superseded | [clm_01624AECDA73](/claim/clm_01624AECDA73.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_research_and_development | 82,000,000 United States dollar | superseded | [clm_A31DD33B4C4E](/claim/clm_A31DD33B4C4E.md)
- 2012-06-30 to 2012-09-30 | money | total_assets | 28,660,000,000 United States dollar | superseded | [clm_369B05470276](/claim/clm_369B05470276.md)
- 2012-06-30 to 2012-09-30 | money | total_equity | 12,912,000,000 United States dollar | superseded | [clm_028F642D4991](/claim/clm_028F642D4991.md)
- 2012-07-18 to 2012-10-25 | money | shares_outstanding | 491,247,996 shares | superseded | [clm_9E311A53413E](/claim/clm_9E311A53413E.md)
- 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 1,549,000,000 United States dollar | superseded | [clm_A3B61BFCDE0B](/claim/clm_A3B61BFCDE0B.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_net_income | 367,000,000 United States dollar | superseded | [clm_1CA9F706E49B](/claim/clm_1CA9F706E49B.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_research_and_development | 74,000,000 United States dollar | superseded | [clm_7E98B99550FD](/claim/clm_7E98B99550FD.md)
- 2012-09-30 to 2012-12-31 | money | total_assets | 29,523,000,000 United States dollar | superseded | [clm_E664F978290D](/claim/clm_E664F978290D.md)
- 2012-09-30 to 2012-12-31 | money | total_equity | 13,355,000,000 United States dollar | superseded | [clm_A74E3F08B553](/claim/clm_A74E3F08B553.md)
- 2012-10-25 to 2013-01-31 | money | shares_outstanding | 491,247,996 shares | superseded | [clm_CE5D3BFB25AD](/claim/clm_CE5D3BFB25AD.md)
- 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 1,561,000,000 United States dollar | superseded | [clm_0C4BE0EE8A42](/claim/clm_0C4BE0EE8A42.md)
- 2012-12-31 to 2013-12-31 | money | net_income | 1,809,000,000 United States dollar | superseded | [clm_5DEE0081EB3E](/claim/clm_5DEE0081EB3E.md)
- 2012-12-31 to 2013-12-31 | money | research_and_development | 348,000,000 United States dollar | superseded | [clm_ADEDF5AD481F](/claim/clm_ADEDF5AD481F.md)
- 2012-12-31 to 2013-12-31 | money | revenue | 9,964,000,000 United States dollar | superseded | [clm_ADED1E740B0B](/claim/clm_ADED1E740B0B.md)
- 2012-12-31 to 2013-03-31 | money | total_assets | 29,650,000,000 United States dollar | superseded | [clm_85B0D079F8CA](/claim/clm_85B0D079F8CA.md)
- 2012-12-31 to 2013-03-31 | money | total_equity | 13,773,000,000 United States dollar | superseded | [clm_14712EAD2EE9](/claim/clm_14712EAD2EE9.md)

## 2013

- 2013-01-31 to 2013-04-22 | money | shares_outstanding | 491,837,641 shares | superseded | [clm_A8160459BDF9](/claim/clm_A8160459BDF9.md)
- 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 1,378,000,000 United States dollar | superseded | [clm_7241171F2CB4](/claim/clm_7241171F2CB4.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_net_income | 315,000,000 United States dollar | superseded | [clm_D27560A690B6](/claim/clm_D27560A690B6.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_research_and_development | 52,000,000 United States dollar | superseded | [clm_65C75FE4E84B](/claim/clm_65C75FE4E84B.md)
- 2013-03-31 to 2013-06-30 | money | total_assets | 29,451,000,000 United States dollar | superseded | [clm_9957284C24E2](/claim/clm_9957284C24E2.md)
- 2013-03-31 to 2013-06-30 | money | total_equity | 13,894,000,000 United States dollar | superseded | [clm_9408A1B9D3F9](/claim/clm_9408A1B9D3F9.md)
- 2013-04-22 to 2013-07-18 | money | shares_outstanding | 492,319,340 shares | superseded | [clm_27A0543FE9A1](/claim/clm_27A0543FE9A1.md)
- 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 1,248,000,000 United States dollar | superseded | [clm_650D645DF009](/claim/clm_650D645DF009.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_net_income | -2,019,000,000 United States dollar | superseded | [clm_3E93EC0277EE](/claim/clm_3E93EC0277EE.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_research_and_development | 46,000,000 United States dollar | superseded | [clm_41A539AC24AE](/claim/clm_41A539AC24AE.md)
- 2013-06-30 to 2013-09-30 | money | total_assets | 26,476,000,000 United States dollar | superseded | [clm_6530748EC9BA](/claim/clm_6530748EC9BA.md)
- 2013-06-30 to 2013-09-30 | money | total_equity | 11,226,000,000 United States dollar | superseded | [clm_351037B77410](/claim/clm_351037B77410.md)
- 2013-07-18 to 2013-10-24 | money | shares_outstanding | 492,822,946 shares | superseded | [clm_F8BE247CEB9E](/claim/clm_F8BE247CEB9E.md)
- 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 1,475,000,000 United States dollar | superseded | [clm_E94E729B10A6](/claim/clm_E94E729B10A6.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_net_income | 408,000,000 United States dollar | superseded | [clm_4E7B6A11CC23](/claim/clm_4E7B6A11CC23.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_research_and_development | 67,000,000 United States dollar | superseded | [clm_19E2724BF9F5](/claim/clm_19E2724BF9F5.md)
- 2013-09-30 to 2013-12-31 | money | total_assets | 26,799,000,000 United States dollar | superseded | [clm_258AB58EF9F6](/claim/clm_258AB58EF9F6.md)
- 2013-09-30 to 2013-12-31 | money | total_equity | 11,533,000,000 United States dollar | superseded | [clm_862850C1D7DF](/claim/clm_862850C1D7DF.md)
- 2013-10-24 to 2014-02-13 | money | shares_outstanding | 493,059,095 shares | superseded | [clm_8EAB79B87EBF](/claim/clm_8EAB79B87EBF.md)
- 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 1,555,000,000 United States dollar | superseded | [clm_4812342ABCA5](/claim/clm_4812342ABCA5.md)
- 2013-12-31 to 2014-12-31 | money | net_income | -2,462,000,000 United States dollar | superseded | [clm_11F516ABB870](/claim/clm_11F516ABB870.md)
- 2013-12-31 to 2014-12-31 | money | research_and_development | 222,000,000 United States dollar | superseded | [clm_7E024482112B](/claim/clm_7E024482112B.md)
- 2013-12-31 to 2014-12-31 | money | revenue | 8,414,000,000 United States dollar | superseded | [clm_BF997F573146](/claim/clm_BF997F573146.md)
- 2013-12-31 to 2014-03-31 | money | total_assets | 24,764,000,000 United States dollar | superseded | [clm_8AEAE3914707](/claim/clm_8AEAE3914707.md)
- 2013-12-31 to 2014-03-31 | money | total_equity | 10,141,000,000 United States dollar | superseded | [clm_15A03EE6BFE4](/claim/clm_15A03EE6BFE4.md)

## 2014

- 2014-02-13 to 2014-04-16 | money | shares_outstanding | 493,245,093 shares | superseded | [clm_B4B8553B2F06](/claim/clm_B4B8553B2F06.md)
- 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 1,475,000,000 United States dollar | superseded | [clm_480A3C6F8E09](/claim/clm_480A3C6F8E09.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_net_income | 100,000,000 United States dollar | superseded | [clm_EBB1A06814AE](/claim/clm_EBB1A06814AE.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_research_and_development | 42,000,000 United States dollar | superseded | [clm_1DF3517DEF4C](/claim/clm_1DF3517DEF4C.md)
- 2014-03-31 to 2014-06-30 | money | total_assets | 24,798,000,000 United States dollar | superseded | [clm_B71DA972F0E9](/claim/clm_B71DA972F0E9.md)
- 2014-03-31 to 2014-06-30 | money | total_equity | 10,019,000,000 United States dollar | superseded | [clm_7171186243A7](/claim/clm_7171186243A7.md)
- 2014-04-16 to 2014-07-18 | money | shares_outstanding | 498,529,240 shares | superseded | [clm_02D890AB5C32](/claim/clm_02D890AB5C32.md)
- 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 1,653,000,000 United States dollar | superseded | [clm_FA41E519E323](/claim/clm_FA41E519E323.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_net_income | 180,000,000 United States dollar | superseded | [clm_7C51CF46EC98](/claim/clm_7C51CF46EC98.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_research_and_development | 42,000,000 United States dollar | superseded | [clm_57B404F43DE2](/claim/clm_57B404F43DE2.md)
- 2014-06-30 to 2014-09-30 | money | total_assets | 24,976,000,000 United States dollar | superseded | [clm_98F330109829](/claim/clm_98F330109829.md)
- 2014-06-30 to 2014-09-30 | money | total_equity | 10,231,000,000 United States dollar | superseded | [clm_C5EA56BD3AE3](/claim/clm_C5EA56BD3AE3.md)
- 2014-07-18 to 2014-10-22 | money | shares_outstanding | 498,758,930 shares | superseded | [clm_89A0114EC627](/claim/clm_89A0114EC627.md)
- 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 1,778,000,000 United States dollar | superseded | [clm_F43FC31B071A](/claim/clm_F43FC31B071A.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_net_income | 213,000,000 United States dollar | superseded | [clm_7E0E14649223](/claim/clm_7E0E14649223.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_research_and_development | 36,000,000 United States dollar | superseded | [clm_13F2CD5B6767](/claim/clm_13F2CD5B6767.md)
- 2014-09-30 to 2014-12-31 | money | total_assets | 25,121,000,000 United States dollar | superseded | [clm_E1D009340757](/claim/clm_E1D009340757.md)
- 2014-09-30 to 2014-12-31 | money | total_equity | 10,381,000,000 United States dollar | superseded | [clm_2DE453D5A349](/claim/clm_2DE453D5A349.md)
- 2014-10-22 to 2015-02-11 | money | shares_outstanding | 498,795,641 shares | superseded | [clm_1CC8F2ED62FC](/claim/clm_1CC8F2ED62FC.md)
- 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 2,403,000,000 United States dollar | superseded | [clm_DB888834F102](/claim/clm_DB888834F102.md)
- 2014-12-31 to 2015-12-31 | money | net_income | 508,000,000 United States dollar | superseded | [clm_C997A937EE2A](/claim/clm_C997A937EE2A.md)
- 2014-12-31 to 2015-12-31 | money | research_and_development | 161,000,000 United States dollar | superseded | [clm_DEAB10CFB779](/claim/clm_DEAB10CFB779.md)
- 2014-12-31 to 2015-12-31 | money | revenue | 7,292,000,000 United States dollar | superseded | [clm_B07B506A8EE8](/claim/clm_B07B506A8EE8.md)
- 2014-12-31 to 2015-03-31 | money | total_assets | 24,916,000,000 United States dollar | superseded | [clm_24926691C8D9](/claim/clm_24926691C8D9.md)
- 2014-12-31 to 2015-03-31 | money | total_equity | 10,274,000,000 United States dollar | superseded | [clm_F121091D7086](/claim/clm_F121091D7086.md)

## 2015

- 2015-02-11 to 2015-04-15 | money | shares_outstanding | 498,857,070 shares | superseded | [clm_48F25D3F731E](/claim/clm_48F25D3F731E.md)
- 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 2,598,000,000 United States dollar | superseded | [clm_D60B9E874323](/claim/clm_D60B9E874323.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_net_income | 183,000,000 United States dollar | superseded | [clm_966270497948](/claim/clm_966270497948.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_research_and_development | 28,000,000 United States dollar | superseded | [clm_7067C3499312](/claim/clm_7067C3499312.md)
- 2015-03-31 to 2015-06-30 | money | total_assets | 25,602,000,000 United States dollar | superseded | [clm_6747E4BA12E0](/claim/clm_6747E4BA12E0.md)
- 2015-03-31 to 2015-06-30 | money | total_equity | 10,462,000,000 United States dollar | superseded | [clm_2138299EDC99](/claim/clm_2138299EDC99.md)
- 2015-04-15 to 2015-07-16 | money | shares_outstanding | 499,846,772 shares | superseded | [clm_4B2F0C1DFD39](/claim/clm_4B2F0C1DFD39.md)
- 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 3,308,000,000 United States dollar | superseded | [clm_FC1CF2F51F92](/claim/clm_FC1CF2F51F92.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_net_income | 72,000,000 United States dollar | superseded | [clm_5BF04FCAC526](/claim/clm_5BF04FCAC526.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_research_and_development | 33,000,000 United States dollar | superseded | [clm_D383E2D86CA4](/claim/clm_D383E2D86CA4.md)
- 2015-06-30 to 2015-09-30 | money | total_assets | 25,961,000,000 United States dollar | superseded | [clm_626D5C291D3B](/claim/clm_626D5C291D3B.md)
- 2015-06-30 to 2015-09-30 | money | total_equity | 11,271,000,000 United States dollar | superseded | [clm_0229875386CC](/claim/clm_0229875386CC.md)
- 2015-07-16 to 2015-10-22 | money | shares_outstanding | 529,054,665 shares | superseded | [clm_C6A5420D2DB8](/claim/clm_C6A5420D2DB8.md)
- 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 2,964,000,000 United States dollar | superseded | [clm_2A7CE7B35939](/claim/clm_2A7CE7B35939.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_net_income | 219,000,000 United States dollar | superseded | [clm_6A2B929968CF](/claim/clm_6A2B929968CF.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_research_and_development | 32,000,000 United States dollar | superseded | [clm_2725C9C5827D](/claim/clm_2725C9C5827D.md)
- 2015-09-30 to 2015-12-31 | money | total_assets | 25,554,000,000 United States dollar | superseded | [clm_7217BF1327D4](/claim/clm_7217BF1327D4.md)
- 2015-09-30 to 2015-12-31 | money | total_equity | 11,544,000,000 United States dollar | superseded | [clm_4750638331A8](/claim/clm_4750638331A8.md)
- 2015-10-22 to 2016-02-09 | money | shares_outstanding | 529,117,504 shares | superseded | [clm_C5E66B1AD849](/claim/clm_C5E66B1AD849.md)
- 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 2,782,000,000 United States dollar | superseded | [clm_D2B6BE3A79B4](/claim/clm_D2B6BE3A79B4.md)
- 2015-12-31 to 2016-12-31 | money | net_income | 220,000,000 United States dollar | superseded | [clm_28710EA0163D](/claim/clm_28710EA0163D.md)
- 2015-12-31 to 2016-12-31 | money | research_and_development | 133,000,000 United States dollar | superseded | [clm_63E836F79DA9](/claim/clm_63E836F79DA9.md)
- 2015-12-31 to 2016-12-31 | money | revenue | 7,729,000,000 United States dollar | superseded | [clm_7C03F562D01A](/claim/clm_7C03F562D01A.md)
- 2015-12-31 to 2016-03-31 | money | total_assets | 25,182,000,000 United States dollar | superseded | [clm_C94AB2E7DF46](/claim/clm_C94AB2E7DF46.md)
- 2015-12-31 to 2016-03-31 | money | total_equity | 11,350,000,000 United States dollar | superseded | [clm_967FE2F7CEA0](/claim/clm_967FE2F7CEA0.md)

## 2016

- 2016-02-09 to 2016-04-13 | money | shares_outstanding | 529,161,509 shares | superseded | [clm_0E3270232DC8](/claim/clm_0E3270232DC8.md)
- 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 2,461,000,000 United States dollar | superseded | [clm_CD20F30FED9C](/claim/clm_CD20F30FED9C.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_net_income | 52,000,000 United States dollar | superseded | [clm_4F595D8842FF](/claim/clm_4F595D8842FF.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_research_and_development | 28,000,000 United States dollar | superseded | [clm_0368FEE39960](/claim/clm_0368FEE39960.md)
- 2016-03-31 to 2016-06-30 | money | total_assets | 24,553,000,000 United States dollar | superseded | [clm_02CE7E005FBB](/claim/clm_02CE7E005FBB.md)
- 2016-03-31 to 2016-06-30 | money | total_equity | 11,349,000,000 United States dollar | superseded | [clm_AF9E916B538D](/claim/clm_AF9E916B538D.md)
- 2016-04-13 to 2016-07-13 | money | shares_outstanding | 530,530,905 shares | superseded | [clm_2C8B7E3EECE4](/claim/clm_2C8B7E3EECE4.md)
- 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 2,902,000,000 United States dollar | superseded | [clm_685FC6FF623B](/claim/clm_685FC6FF623B.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_net_income | 23,000,000 United States dollar | superseded | [clm_9B23B81FCABB](/claim/clm_9B23B81FCABB.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_research_and_development | 44,000,000 United States dollar | superseded | [clm_D076E55699D2](/claim/clm_D076E55699D2.md)
- 2016-06-30 to 2016-09-30 | money | total_assets | 24,703,000,000 United States dollar | superseded | [clm_774ADFD6A1A0](/claim/clm_774ADFD6A1A0.md)
- 2016-06-30 to 2016-09-30 | money | total_equity | 11,423,000,000 United States dollar | superseded | [clm_403EF7AB02FC](/claim/clm_403EF7AB02FC.md)
- 2016-07-13 to 2016-10-19 | money | shares_outstanding | 530,594,563 shares | superseded | [clm_DFB84CB0E260](/claim/clm_DFB84CB0E260.md)
- 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 2,099,000,000 United States dollar | superseded | [clm_D3D743D55485](/claim/clm_D3D743D55485.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_net_income | -358,000,000 United States dollar | superseded | [clm_55CB7CED568D](/claim/clm_55CB7CED568D.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 34,000,000 United States dollar | superseded | [clm_0730102DC325](/claim/clm_0730102DC325.md)
- 2016-09-30 to 2016-12-31 | money | total_assets | 24,081,000,000 United States dollar | superseded | [clm_1E69D6071D7A](/claim/clm_1E69D6071D7A.md)
- 2016-09-30 to 2016-12-31 | money | total_equity | 11,102,000,000 United States dollar | superseded | [clm_2DCC3D8FDE78](/claim/clm_2DCC3D8FDE78.md)
- 2016-10-19 to 2017-02-14 | money | shares_outstanding | 530,750,074 shares | superseded | [clm_90D914B2CB25](/claim/clm_90D914B2CB25.md)
- 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 2,756,000,000 United States dollar | superseded | [clm_92290FE0F6E0](/claim/clm_92290FE0F6E0.md)
- 2016-12-31 to 2017-12-31 | money | net_income | -627,000,000 United States dollar | superseded | [clm_29DD0E4CC222](/claim/clm_29DD0E4CC222.md)
- 2016-12-31 to 2017-12-31 | money | research_and_development | 134,000,000 United States dollar | superseded | [clm_15FFB123AFB7](/claim/clm_15FFB123AFB7.md)
- 2016-12-31 to 2017-12-31 | money | revenue | 6,711,000,000 United States dollar | superseded | [clm_652B095C767A](/claim/clm_652B095C767A.md)
- 2016-12-31 to 2017-03-31 | money | total_assets | 21,031,000,000 United States dollar | superseded | [clm_4ADC60D87AD3](/claim/clm_4ADC60D87AD3.md)
- 2016-12-31 to 2017-03-31 | money | total_equity | 10,721,000,000 United States dollar | superseded | [clm_ECC719E04C72](/claim/clm_ECC719E04C72.md)

## 2017

- 2017-02-14 to 2017-04-17 | money | shares_outstanding | 531,149,818 shares | superseded | [clm_87C1FC55DF59](/claim/clm_87C1FC55DF59.md)
- 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 2,919,000,000 United States dollar | superseded | [clm_43B58AFD5F45](/claim/clm_43B58AFD5F45.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_net_income | 46,000,000 United States dollar | superseded | [clm_7E275135BE9E](/claim/clm_7E275135BE9E.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 26,000,000 United States dollar | superseded | [clm_CCD0C0CB5EFB](/claim/clm_CCD0C0CB5EFB.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 1,690,000,000 United States dollar | superseded | [clm_E0E4D8B3BCF7](/claim/clm_E0E4D8B3BCF7.md)
- 2017-03-31 to 2017-06-30 | money | total_assets | 20,969,000,000 United States dollar | superseded | [clm_87FB17B5E007](/claim/clm_87FB17B5E007.md)
- 2017-03-31 to 2017-06-30 | money | total_equity | 10,755,000,000 United States dollar | superseded | [clm_FC98718EA81F](/claim/clm_FC98718EA81F.md)
- 2017-04-17 to 2017-07-17 | money | shares_outstanding | 533,233,294 shares | superseded | [clm_3AC82525C05D](/claim/clm_3AC82525C05D.md)
- 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 3,105,000,000 United States dollar | superseded | [clm_876C9092CFB2](/claim/clm_876C9092CFB2.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_net_income | 177,000,000 United States dollar | superseded | [clm_6B109461294F](/claim/clm_6B109461294F.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_research_and_development | 32,000,000 United States dollar | superseded | [clm_39AC61F400AC](/claim/clm_39AC61F400AC.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 1,875,000,000 United States dollar | superseded | [clm_27CCFCA3A880](/claim/clm_27CCFCA3A880.md)
- 2017-06-30 to 2017-09-30 | money | total_assets | 21,142,000,000 United States dollar | superseded | [clm_BD53E202B07A](/claim/clm_BD53E202B07A.md)
- 2017-06-30 to 2017-09-30 | money | total_equity | 10,928,000,000 United States dollar | superseded | [clm_1610588B7BB8](/claim/clm_1610588B7BB8.md)
- 2017-07-17 to 2017-10-19 | money | shares_outstanding | 533,271,501 shares | superseded | [clm_0B97224E5B6A](/claim/clm_0B97224E5B6A.md)
- 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 2,969,000,000 United States dollar | superseded | [clm_BCA2D10C2E03](/claim/clm_BCA2D10C2E03.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_net_income | 206,000,000 United States dollar | superseded | [clm_0087135E54EE](/claim/clm_0087135E54EE.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_research_and_development | 41,000,000 United States dollar | superseded | [clm_CC4143132606](/claim/clm_CC4143132606.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 1,879,000,000 United States dollar | superseded | [clm_D10B5D92EE38](/claim/clm_D10B5D92EE38.md)
- 2017-09-30 to 2017-12-31 | money | total_assets | 20,836,000,000 United States dollar | superseded | [clm_D23E7DF965C1](/claim/clm_D23E7DF965C1.md)
- 2017-09-30 to 2017-12-31 | money | total_equity | 11,138,000,000 United States dollar | superseded | [clm_245C680E1217](/claim/clm_245C680E1217.md)
- 2017-10-19 to 2018-02-15 | money | shares_outstanding | 533,336,470 shares | superseded | [clm_491DB166FA70](/claim/clm_491DB166FA70.md)
- 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 3,259,000,000 United States dollar | superseded | [clm_6A0746D32C5A](/claim/clm_6A0746D32C5A.md)
- 2017-12-31 to 2018-12-31 | money | net_income | -98,000,000 United States dollar | superseded | [clm_294DE588A90E](/claim/clm_294DE588A90E.md)
- 2017-12-31 to 2018-12-31 | money | research_and_development | 143,000,000 United States dollar | superseded | [clm_FA6D301059AD](/claim/clm_FA6D301059AD.md)
- 2017-12-31 to 2018-12-31 | money | revenue | 7,379,000,000 United States dollar | superseded | [clm_0CEA1D399E5C](/claim/clm_0CEA1D399E5C.md)
- 2017-12-31 to 2018-03-31 | money | total_assets | 20,563,000,000 United States dollar | superseded | [clm_975EB4A9174B](/claim/clm_975EB4A9174B.md)
- 2017-12-31 to 2018-03-31 | money | total_equity | 10,609,000,000 United States dollar | superseded | [clm_C107C0A21D27](/claim/clm_C107C0A21D27.md)

## 2018

- 2018-02-15 to 2018-04-19 | money | shares_outstanding | 533,474,863 shares | superseded | [clm_98CAA2D7D173](/claim/clm_98CAA2D7D173.md)
- 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 3,111,000,000 United States dollar | superseded | [clm_BF9AC4BFAD85](/claim/clm_BF9AC4BFAD85.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 192,000,000 United States dollar | superseded | [clm_7BA3ECB90713](/claim/clm_7BA3ECB90713.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 34,000,000 United States dollar | superseded | [clm_30AE43FD8E9A](/claim/clm_30AE43FD8E9A.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 1,817,000,000 United States dollar | superseded | [clm_DAEFBDC1A80E](/claim/clm_DAEFBDC1A80E.md)
- 2018-03-31 to 2018-06-30 | money | total_assets | 20,483,000,000 United States dollar | superseded | [clm_299AB9B82990](/claim/clm_299AB9B82990.md)
- 2018-03-31 to 2018-06-30 | money | total_equity | 10,575,000,000 United States dollar | superseded | [clm_461A74525E69](/claim/clm_461A74525E69.md)
- 2018-04-19 to 2018-07-19 | money | shares_outstanding | 533,486,402 shares | superseded | [clm_B9E86F32679C](/claim/clm_B9E86F32679C.md)
- 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 3,127,000,000 United States dollar | superseded | [clm_7928A69B34F2](/claim/clm_7928A69B34F2.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_net_income | 292,000,000 United States dollar | superseded | [clm_E783A066D113](/claim/clm_E783A066D113.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 36,000,000 United States dollar | superseded | [clm_32230FF371EF](/claim/clm_32230FF371EF.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 1,662,000,000 United States dollar | superseded | [clm_1821CCD1202D](/claim/clm_1821CCD1202D.md)
- 2018-06-30 to 2018-09-30 | money | total_assets | 20,655,000,000 United States dollar | superseded | [clm_8A96E0ADD0F8](/claim/clm_8A96E0ADD0F8.md)
- 2018-06-30 to 2018-09-30 | money | total_equity | 10,813,000,000 United States dollar | superseded | [clm_3D0FC58107E2](/claim/clm_3D0FC58107E2.md)
- 2018-07-19 to 2018-10-18 | money | shares_outstanding | 533,398,733 shares | superseded | [clm_14D5AD720520](/claim/clm_14D5AD720520.md)
- 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 3,068,000,000 United States dollar | superseded | [clm_2F755D80F156](/claim/clm_2F755D80F156.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_net_income | -145,000,000 United States dollar | superseded | [clm_FC8ED7DB800E](/claim/clm_FC8ED7DB800E.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 37,000,000 United States dollar | superseded | [clm_00FC5679DBCA](/claim/clm_00FC5679DBCA.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 1,726,000,000 United States dollar | superseded | [clm_0F77DA24B0CF](/claim/clm_0F77DA24B0CF.md)
- 2018-09-30 to 2018-12-31 | money | total_assets | 20,559,000,000 United States dollar | superseded | [clm_AAD9635A47B3](/claim/clm_AAD9635A47B3.md)
- 2018-09-30 to 2018-12-31 | money | total_equity | 10,597,000,000 United States dollar | superseded | [clm_51497199DE56](/claim/clm_51497199DE56.md)
- 2018-10-18 to 2019-02-14 | money | shares_outstanding | 532,660,228 shares | superseded | [clm_B7ACD3050329](/claim/clm_B7ACD3050329.md)
- 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 3,397,000,000 United States dollar | superseded | [clm_71C7C51C76B4](/claim/clm_71C7C51C76B4.md)
- 2018-12-31 to 2019-12-31 | money | net_income | 341,000,000 United States dollar | superseded | [clm_A151E94F903C](/claim/clm_A151E94F903C.md)
- 2018-12-31 to 2019-12-31 | money | research_and_development | 153,000,000 United States dollar | superseded | [clm_CEAA723AD85C](/claim/clm_CEAA723AD85C.md)
- 2018-12-31 to 2019-12-31 | money | revenue | 7,253,000,000 United States dollar | superseded | [clm_D85140DE3EB2](/claim/clm_D85140DE3EB2.md)
- 2018-12-31 to 2019-03-31 | money | total_assets | 20,715,000,000 United States dollar | superseded | [clm_19235B2F8A33](/claim/clm_19235B2F8A33.md)
- 2018-12-31 to 2019-03-31 | money | total_equity | 10,502,000,000 United States dollar | superseded | [clm_105FD922ACE9](/claim/clm_105FD922ACE9.md)

## 2019

- 2019-02-14 to 2019-04-18 | money | shares_outstanding | 532,669,445 shares | superseded | [clm_2ECA6501A6D7](/claim/clm_2ECA6501A6D7.md)
- 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 3,545,000,000 United States dollar | superseded | [clm_8A09A123E2A6](/claim/clm_8A09A123E2A6.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 87,000,000 United States dollar | superseded | [clm_30B2407C1F43](/claim/clm_30B2407C1F43.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 27,000,000 United States dollar | superseded | [clm_FC3E1B60C98E](/claim/clm_FC3E1B60C98E.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 1,803,000,000 United States dollar | superseded | [clm_AB77EDE42C77](/claim/clm_AB77EDE42C77.md)
- 2019-03-31 to 2019-06-30 | money | total_assets | 20,880,000,000 United States dollar | superseded | [clm_91546A07676A](/claim/clm_91546A07676A.md)
- 2019-03-31 to 2019-06-30 | money | total_equity | 10,499,000,000 United States dollar | superseded | [clm_ACC9BEC43204](/claim/clm_ACC9BEC43204.md)
- 2019-04-18 to 2019-07-18 | money | shares_outstanding | 819,633,497 shares | superseded | [clm_755B202309E5](/claim/clm_755B202309E5.md)
- 2019-04-22 to 2020-01-03 | other | registrant_name | NEWMONT GOLDCORP CORP /DE/ | superseded | [clm_7FA3511F549B](/claim/clm_7FA3511F549B.md)
- 2019-06-30 to 2019-09-30 | money | cash_and_equivalents | 1,827,000,000 United States dollar | superseded | [clm_0F91BA5A343E](/claim/clm_0F91BA5A343E.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_net_income | -25,000,000 United States dollar | superseded | [clm_BF326764BC1C](/claim/clm_BF326764BC1C.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 32,000,000 United States dollar | superseded | [clm_B5CF1EA5C84B](/claim/clm_B5CF1EA5C84B.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 2,257,000,000 United States dollar | superseded | [clm_086B29EC3FA3](/claim/clm_086B29EC3FA3.md)
- 2019-06-30 to 2019-09-30 | money | total_assets | 36,987,000,000 United States dollar | superseded | [clm_CBB73421FF9F](/claim/clm_CBB73421FF9F.md)
- 2019-06-30 to 2019-09-30 | money | total_equity | 19,354,000,000 United States dollar | superseded | [clm_04C0E9B9EF67](/claim/clm_04C0E9B9EF67.md)
- 2019-07-18 to 2019-10-29 | money | shares_outstanding | 819,893,825 shares | superseded | [clm_D0174B0E6C05](/claim/clm_D0174B0E6C05.md)
- 2019-09-30 to 2019-12-31 | money | cash_and_equivalents | 2,712,000,000 United States dollar | superseded | [clm_654112BA0BF8](/claim/clm_654112BA0BF8.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_net_income | 2,178,000,000 United States dollar | superseded | [clm_FD53721E2874](/claim/clm_FD53721E2874.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 43,000,000 United States dollar | superseded | [clm_8298509B72E5](/claim/clm_8298509B72E5.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 2,713,000,000 United States dollar | superseded | [clm_8E9C4C416D79](/claim/clm_8E9C4C416D79.md)
- 2019-09-30 to 2019-12-31 | money | total_assets | 40,763,000,000 United States dollar | superseded | [clm_321BDD714A10](/claim/clm_321BDD714A10.md)
- 2019-09-30 to 2019-12-31 | money | total_equity | 21,430,000,000 United States dollar | superseded | [clm_62FF38F0ABE6](/claim/clm_62FF38F0ABE6.md)
- 2019-10-29 to 2020-02-13 | money | shares_outstanding | 819,838,680 shares | superseded | [clm_1073BAF085CB](/claim/clm_1073BAF085CB.md)
- 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 2,243,000,000 United States dollar | superseded | [clm_FA3A2DD88236](/claim/clm_FA3A2DD88236.md)
- 2019-12-31 to 2020-12-31 | money | net_income | 2,805,000,000 United States dollar | superseded | [clm_8B2FC45DE091](/claim/clm_8B2FC45DE091.md)
- 2019-12-31 to 2020-12-31 | money | research_and_development | 150,000,000 United States dollar | superseded | [clm_D34D682F2A3F](/claim/clm_D34D682F2A3F.md)
- 2019-12-31 to 2020-12-31 | money | revenue | 9,740,000,000 United States dollar | superseded | [clm_4123E788D87D](/claim/clm_4123E788D87D.md)
- 2019-12-31 to 2020-03-31 | money | total_assets | 39,974,000,000 United States dollar | superseded | [clm_0F662FC0680B](/claim/clm_0F662FC0680B.md)
- 2019-12-31 to 2020-03-31 | money | total_equity | 21,420,000,000 United States dollar | superseded | [clm_533E4DA76007](/claim/clm_533E4DA76007.md)

## 2020

- 2020-01-03 | other | registrant_name | NEWMONT Corp /DE/ | valid | [clm_9C8FA9F7FA0F](/claim/clm_9C8FA9F7FA0F.md)
- 2020-02-13 to 2020-04-28 | money | shares_outstanding | 807,583,184 shares | superseded | [clm_6C69B331685E](/claim/clm_6C69B331685E.md)
- 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 3,709,000,000 United States dollar | superseded | [clm_30D9BD09078E](/claim/clm_30D9BD09078E.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_net_income | 822,000,000 United States dollar | superseded | [clm_4F30B835AC52](/claim/clm_4F30B835AC52.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 27,000,000 United States dollar | superseded | [clm_12CB7DC171B1](/claim/clm_12CB7DC171B1.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 2,581,000,000 United States dollar | superseded | [clm_AF5C8F2D7252](/claim/clm_AF5C8F2D7252.md)
- 2020-03-31 to 2020-06-30 | money | total_assets | 39,699,000,000 United States dollar | superseded | [clm_C8A7F1A362AC](/claim/clm_C8A7F1A362AC.md)
- 2020-03-31 to 2020-06-30 | money | total_equity | 21,806,000,000 United States dollar | superseded | [clm_5EA4B08C94E9](/claim/clm_5EA4B08C94E9.md)
- 2020-04-28 to 2020-07-23 | money | shares_outstanding | 802,584,618 shares | superseded | [clm_9A61482A641B](/claim/clm_9A61482A641B.md)
- 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 3,808,000,000 United States dollar | superseded | [clm_EBDB742D1B2C](/claim/clm_EBDB742D1B2C.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_net_income | 344,000,000 United States dollar | superseded | [clm_4500AE3B521B](/claim/clm_4500AE3B521B.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 26,000,000 United States dollar | superseded | [clm_2C45866730B0](/claim/clm_2C45866730B0.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 2,365,000,000 United States dollar | superseded | [clm_9BBAAABCCA4F](/claim/clm_9BBAAABCCA4F.md)
- 2020-06-30 to 2020-09-30 | money | total_assets | 39,885,000,000 United States dollar | superseded | [clm_667F919B3547](/claim/clm_667F919B3547.md)
- 2020-06-30 to 2020-09-30 | money | total_equity | 22,004,000,000 United States dollar | superseded | [clm_A02813117C12](/claim/clm_A02813117C12.md)
- 2020-07-23 to 2020-10-22 | money | shares_outstanding | 803,071,105 shares | superseded | [clm_536778B4D5D8](/claim/clm_536778B4D5D8.md)
- 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 4,828,000,000 United States dollar | superseded | [clm_EFF04B560F55](/claim/clm_EFF04B560F55.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_net_income | 839,000,000 United States dollar | superseded | [clm_9D0EF26707E2](/claim/clm_9D0EF26707E2.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 39,000,000 United States dollar | superseded | [clm_65C18D45BC39](/claim/clm_65C18D45BC39.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 3,170,000,000 United States dollar | superseded | [clm_2F8E848DA750](/claim/clm_2F8E848DA750.md)
- 2020-09-30 to 2020-12-31 | money | total_assets | 40,551,000,000 United States dollar | superseded | [clm_6B4C8C1B3DAD](/claim/clm_6B4C8C1B3DAD.md)
- 2020-09-30 to 2020-12-31 | money | total_equity | 22,661,000,000 United States dollar | superseded | [clm_AA9A38443C95](/claim/clm_AA9A38443C95.md)
- 2020-10-22 to 2021-02-11 | money | shares_outstanding | 803,358,053 shares | superseded | [clm_FC1029036DED](/claim/clm_FC1029036DED.md)
- 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 5,540,000,000 United States dollar | superseded | [clm_840F414A28BF](/claim/clm_840F414A28BF.md)
- 2020-12-31 to 2021-12-31 | money | net_income | 2,829,000,000 United States dollar | superseded | [clm_35E057FC5A11](/claim/clm_35E057FC5A11.md)
- 2020-12-31 to 2021-12-31 | money | research_and_development | 122,000,000 United States dollar | superseded | [clm_A0C8E648890F](/claim/clm_A0C8E648890F.md)
- 2020-12-31 to 2021-12-31 | money | revenue | 11,497,000,000 United States dollar | superseded | [clm_58245E5C8961](/claim/clm_58245E5C8961.md)
- 2020-12-31 to 2021-03-31 | money | total_assets | 41,369,000,000 United States dollar | superseded | [clm_0234725631E1](/claim/clm_0234725631E1.md)
- 2020-12-31 to 2021-03-31 | money | total_equity | 23,008,000,000 United States dollar | superseded | [clm_ABBB44027DD4](/claim/clm_ABBB44027DD4.md)

## 2021

- 2021-02-11 to 2021-04-22 | money | shares_outstanding | 800,314,223 shares | superseded | [clm_E2BA5AF9D733](/claim/clm_E2BA5AF9D733.md)
- 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 5,518,000,000 United States dollar | superseded | [clm_D8D4760E05CF](/claim/clm_D8D4760E05CF.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_net_income | 559,000,000 United States dollar | superseded | [clm_13BBA3A6FC64](/claim/clm_13BBA3A6FC64.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 31,000,000 United States dollar | superseded | [clm_3E03ADAF444F](/claim/clm_3E03ADAF444F.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 2,872,000,000 United States dollar | superseded | [clm_31D5EE3499EB](/claim/clm_31D5EE3499EB.md)
- 2021-03-31 to 2021-06-30 | money | total_assets | 41,063,000,000 United States dollar | superseded | [clm_C9B96303C26E](/claim/clm_C9B96303C26E.md)
- 2021-03-31 to 2021-06-30 | money | total_equity | 23,127,000,000 United States dollar | superseded | [clm_68D1AB97B1D1](/claim/clm_68D1AB97B1D1.md)
- 2021-04-22 to 2021-07-15 | money | shares_outstanding | 801,161,942 shares | superseded | [clm_C7CA53D01A52](/claim/clm_C7CA53D01A52.md)
- 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 4,583,000,000 United States dollar | superseded | [clm_A52B2D5D5818](/claim/clm_A52B2D5D5818.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 650,000,000 United States dollar | superseded | [clm_F0DBA620BE09](/claim/clm_F0DBA620BE09.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 37,000,000 United States dollar | superseded | [clm_A8F4938011B1](/claim/clm_A8F4938011B1.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 3,065,000,000 United States dollar | superseded | [clm_2182787A751B](/claim/clm_2182787A751B.md)
- 2021-06-30 to 2021-09-30 | money | total_assets | 40,677,000,000 United States dollar | superseded | [clm_B99839D31911](/claim/clm_B99839D31911.md)
- 2021-06-30 to 2021-09-30 | money | total_equity | 23,239,000,000 United States dollar | superseded | [clm_D78E7B367B31](/claim/clm_D78E7B367B31.md)
- 2021-07-15 to 2021-10-21 | money | shares_outstanding | 799,126,123 shares | superseded | [clm_B57642A30438](/claim/clm_B57642A30438.md)
- 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 4,636,000,000 United States dollar | superseded | [clm_789FE608945C](/claim/clm_789FE608945C.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_net_income | 3,000,000 United States dollar | superseded | [clm_309D75AA89D4](/claim/clm_309D75AA89D4.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 40,000,000 United States dollar | superseded | [clm_88B129314E08](/claim/clm_88B129314E08.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 2,895,000,000 United States dollar | superseded | [clm_14BF40064C72](/claim/clm_14BF40064C72.md)
- 2021-09-30 to 2021-12-31 | money | total_assets | 39,865,000,000 United States dollar | superseded | [clm_228DC8F0BB9E](/claim/clm_228DC8F0BB9E.md)
- 2021-09-30 to 2021-12-31 | money | total_equity | 22,712,000,000 United States dollar | superseded | [clm_230395437E6D](/claim/clm_230395437E6D.md)
- 2021-10-21 to 2022-02-17 | money | shares_outstanding | 797,435,304 shares | superseded | [clm_7F8CD2DB91EA](/claim/clm_7F8CD2DB91EA.md)
- 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 4,992,000,000 United States dollar | superseded | [clm_9B67F05B72B2](/claim/clm_9B67F05B72B2.md)
- 2021-12-31 to 2022-12-31 | money | net_income | 1,166,000,000 United States dollar | superseded | [clm_911613B2368F](/claim/clm_911613B2368F.md)
- 2021-12-31 to 2022-12-31 | money | research_and_development | 154,000,000 United States dollar | superseded | [clm_F2CA94CFB45B](/claim/clm_F2CA94CFB45B.md)
- 2021-12-31 to 2022-12-31 | money | revenue | 12,222,000,000 United States dollar | superseded | [clm_86C22E601872](/claim/clm_86C22E601872.md)
- 2021-12-31 to 2022-03-31 | money | total_assets | 40,564,000,000 United States dollar | superseded | [clm_228D7CB4CEC6](/claim/clm_228D7CB4CEC6.md)
- 2021-12-31 to 2022-03-31 | money | total_equity | 22,022,000,000 United States dollar | superseded | [clm_71A3B4AF6D0E](/claim/clm_71A3B4AF6D0E.md)

## 2022

- 2022-02-17 to 2022-04-18 | money | shares_outstanding | 792,502,327 shares | superseded | [clm_FFC6A2DF6E45](/claim/clm_FFC6A2DF6E45.md)
- 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 4,272,000,000 United States dollar | superseded | [clm_3C570F3D5FD0](/claim/clm_3C570F3D5FD0.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_net_income | 448,000,000 United States dollar | superseded | [clm_AF65B144FC1D](/claim/clm_AF65B144FC1D.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_research_and_development | 44,000,000 United States dollar | superseded | [clm_BAC4758B5641](/claim/clm_BAC4758B5641.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 3,023,000,000 United States dollar | superseded | [clm_6404B24BD081](/claim/clm_6404B24BD081.md)
- 2022-03-31 to 2022-06-30 | money | total_assets | 39,913,000,000 United States dollar | superseded | [clm_45BAEA9074FD](/claim/clm_45BAEA9074FD.md)
- 2022-03-31 to 2022-06-30 | money | total_equity | 21,449,000,000 United States dollar | superseded | [clm_644AD9EEC48E](/claim/clm_644AD9EEC48E.md)
- 2022-04-18 to 2022-07-18 | money | shares_outstanding | 793,651,139 shares | superseded | [clm_88485DBA6106](/claim/clm_88485DBA6106.md)
- 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 4,307,000,000 United States dollar | superseded | [clm_924066E15144](/claim/clm_924066E15144.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 387,000,000 United States dollar | superseded | [clm_5CCAEB25D36C](/claim/clm_5CCAEB25D36C.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_research_and_development | 45,000,000 United States dollar | superseded | [clm_1642158F11CA](/claim/clm_1642158F11CA.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 3,058,000,000 United States dollar | superseded | [clm_8EA9E6F0F881](/claim/clm_8EA9E6F0F881.md)
- 2022-06-30 to 2022-09-30 | money | total_assets | 39,690,000,000 United States dollar | superseded | [clm_43446FC2CCD8](/claim/clm_43446FC2CCD8.md)
- 2022-06-30 to 2022-09-30 | money | total_equity | 21,421,000,000 United States dollar | superseded | [clm_2E4619FBB73F](/claim/clm_2E4619FBB73F.md)
- 2022-07-18 to 2022-10-25 | money | shares_outstanding | 793,680,485 shares | superseded | [clm_A908943B33E8](/claim/clm_A908943B33E8.md)
- 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 3,058,000,000 United States dollar | superseded | [clm_A3D1991FB065](/claim/clm_A3D1991FB065.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_net_income | 213,000,000 United States dollar | superseded | [clm_C22004BA2DA1](/claim/clm_C22004BA2DA1.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 80,000,000 United States dollar | superseded | [clm_4F33F5FDADE2](/claim/clm_4F33F5FDADE2.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 2,634,000,000 United States dollar | superseded | [clm_1DCF7FA75AA0](/claim/clm_1DCF7FA75AA0.md)
- 2022-09-30 to 2022-12-31 | money | total_assets | 39,143,000,000 United States dollar | superseded | [clm_A02562729B38](/claim/clm_A02562729B38.md)
- 2022-09-30 to 2022-12-31 | money | total_equity | 21,219,000,000 United States dollar | superseded | [clm_CC46D2BE0463](/claim/clm_CC46D2BE0463.md)
- 2022-10-25 to 2023-02-16 | money | shares_outstanding | 793,738,731 shares | superseded | [clm_E3AF176887DC](/claim/clm_E3AF176887DC.md)
- 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 2,877,000,000 United States dollar | superseded | [clm_A8E3F1F211CF](/claim/clm_A8E3F1F211CF.md)
- 2022-12-31 to 2023-12-31 | money | net_income | -429,000,000 United States dollar | superseded | [clm_988BEDE5CA5D](/claim/clm_988BEDE5CA5D.md)
- 2022-12-31 to 2023-12-31 | money | research_and_development | 229,000,000 United States dollar | superseded | [clm_4AA2404294DA](/claim/clm_4AA2404294DA.md)
- 2022-12-31 to 2023-12-31 | money | revenue | 11,915,000,000 United States dollar | superseded | [clm_606BDD7BB9CE](/claim/clm_606BDD7BB9CE.md)
- 2022-12-31 to 2023-03-31 | money | total_assets | 38,482,000,000 United States dollar | superseded | [clm_0061B6C296F0](/claim/clm_0061B6C296F0.md)
- 2022-12-31 to 2023-03-31 | money | total_equity | 19,354,000,000 United States dollar | superseded | [clm_90CBB9C1DEDA](/claim/clm_90CBB9C1DEDA.md)

## 2023

- 2023-02-16 to 2023-04-20 | money | shares_outstanding | 793,794,062 shares | superseded | [clm_9A1F3447E373](/claim/clm_9A1F3447E373.md)
- 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 2,657,000,000 United States dollar | superseded | [clm_EBBC239B2145](/claim/clm_EBBC239B2145.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 351,000,000 United States dollar | superseded | [clm_080130530CA9](/claim/clm_080130530CA9.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 35,000,000 United States dollar | superseded | [clm_2B0C4FF8F744](/claim/clm_2B0C4FF8F744.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 2,679,000,000 United States dollar | superseded | [clm_DB3CE2E5BC20](/claim/clm_DB3CE2E5BC20.md)
- 2023-03-31 to 2023-06-30 | money | total_assets | 38,374,000,000 United States dollar | superseded | [clm_1D99EE9A7949](/claim/clm_1D99EE9A7949.md)
- 2023-03-31 to 2023-06-30 | money | total_equity | 19,377,000,000 United States dollar | superseded | [clm_C554529B217E](/claim/clm_C554529B217E.md)
- 2023-04-20 to 2023-07-13 | money | shares_outstanding | 794,712,201 shares | superseded | [clm_95A556969EEF](/claim/clm_95A556969EEF.md)
- 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 2,829,000,000 United States dollar | superseded | [clm_A4F2F87EE82E](/claim/clm_A4F2F87EE82E.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_net_income | 155,000,000 United States dollar | superseded | [clm_F5643CB6D8AC](/claim/clm_F5643CB6D8AC.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_research_and_development | 44,000,000 United States dollar | superseded | [clm_E068D1762F0D](/claim/clm_E068D1762F0D.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 2,683,000,000 United States dollar | superseded | [clm_17B6E590404A](/claim/clm_17B6E590404A.md)
- 2023-06-30 to 2023-09-30 | money | total_assets | 38,133,000,000 United States dollar | superseded | [clm_83D209BC6200](/claim/clm_83D209BC6200.md)
- 2023-06-30 to 2023-09-30 | money | total_equity | 19,225,000,000 United States dollar | superseded | [clm_F4BF6511A981](/claim/clm_F4BF6511A981.md)
- 2023-07-13 to 2023-10-19 | money | shares_outstanding | 794,732,443 shares | superseded | [clm_8450B4F7A623](/claim/clm_8450B4F7A623.md)
- 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 3,190,000,000 United States dollar | superseded | [clm_E44D67918111](/claim/clm_E44D67918111.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_net_income | 158,000,000 United States dollar | superseded | [clm_254343791FD8](/claim/clm_254343791FD8.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_research_and_development | 53,000,000 United States dollar | superseded | [clm_5876940A29B2](/claim/clm_5876940A29B2.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 2,493,000,000 United States dollar | superseded | [clm_77A92FFD1337](/claim/clm_77A92FFD1337.md)
- 2023-09-30 to 2023-12-31 | money | total_assets | 38,084,000,000 United States dollar | superseded | [clm_C1BDFBC91551](/claim/clm_C1BDFBC91551.md)
- 2023-09-30 to 2023-12-31 | money | total_equity | 19,074,000,000 United States dollar | superseded | [clm_BCAE2D10E1CB](/claim/clm_BCAE2D10E1CB.md)
- 2023-10-19 to 2024-02-15 | money | shares_outstanding | 794,800,193 shares | superseded | [clm_4227AF1EB6DA](/claim/clm_4227AF1EB6DA.md)
- 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 3,002,000,000 United States dollar | superseded | [clm_172DD27E204E](/claim/clm_172DD27E204E.md)
- 2023-12-31 to 2024-12-31 | money | net_income | -2,494,000,000 United States dollar | superseded | [clm_960760AAAC2D](/claim/clm_960760AAAC2D.md)
- 2023-12-31 to 2024-12-31 | money | research_and_development | 200,000,000 United States dollar | superseded | [clm_324E1A71C520](/claim/clm_324E1A71C520.md)
- 2023-12-31 to 2024-12-31 | money | revenue | 11,812,000,000 United States dollar | superseded | [clm_F43E6BBA2E50](/claim/clm_F43E6BBA2E50.md)
- 2023-12-31 to 2024-03-31 | money | total_assets | 55,506,000,000 United States dollar | superseded | [clm_C2934666C453](/claim/clm_C2934666C453.md)
- 2023-12-31 to 2024-03-31 | money | total_equity | 29,027,000,000 United States dollar | superseded | [clm_54B88FB5D5ED](/claim/clm_54B88FB5D5ED.md)

## 2024

- 2024-02-15 to 2024-04-22 | money | shares_outstanding | 1,152,551,607 shares | superseded | [clm_2A2B3A226B1F](/claim/clm_2A2B3A226B1F.md)
- 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 2,336,000,000 United States dollar | superseded | [clm_96FF1ED6161E](/claim/clm_96FF1ED6161E.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_net_income | 170,000,000 United States dollar | superseded | [clm_9CB96814D815](/claim/clm_9CB96814D815.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_research_and_development | 53,000,000 United States dollar | superseded | [clm_CC302D76B88D](/claim/clm_CC302D76B88D.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 4,023,000,000 United States dollar | superseded | [clm_240BD2351CEF](/claim/clm_240BD2351CEF.md)
- 2024-03-31 to 2024-06-30 | money | total_assets | 55,335,000,000 United States dollar | superseded | [clm_C1A608C12AD5](/claim/clm_C1A608C12AD5.md)
- 2024-03-31 to 2024-06-30 | money | total_equity | 28,890,000,000 United States dollar | superseded | [clm_513FB80654B1](/claim/clm_513FB80654B1.md)
- 2024-04-22 to 2024-07-18 | money | shares_outstanding | 1,153,140,195 shares | superseded | [clm_10D1DEDA28BF](/claim/clm_10D1DEDA28BF.md)
- 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 2,602,000,000 United States dollar | superseded | [clm_773EA53ED8E5](/claim/clm_773EA53ED8E5.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_net_income | 853,000,000 United States dollar | superseded | [clm_1BA9453A8C41](/claim/clm_1BA9453A8C41.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_research_and_development | 49,000,000 United States dollar | superseded | [clm_E1F102E4F235](/claim/clm_E1F102E4F235.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 4,402,000,000 United States dollar | superseded | [clm_F48EA1B0118B](/claim/clm_F48EA1B0118B.md)
- 2024-06-30 to 2024-09-30 | money | total_assets | 55,678,000,000 United States dollar | superseded | [clm_B5FACFFD22FD](/claim/clm_B5FACFFD22FD.md)
- 2024-06-30 to 2024-09-30 | money | total_equity | 29,379,000,000 United States dollar | superseded | [clm_2C6C4DB2FD56](/claim/clm_2C6C4DB2FD56.md)
- 2024-07-18 to 2024-10-17 | money | shares_outstanding | 1,147,429,288 shares | superseded | [clm_4E86A835C96A](/claim/clm_4E86A835C96A.md)
- 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 3,016,000,000 United States dollar | superseded | [clm_802CA6319281](/claim/clm_802CA6319281.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_net_income | 922,000,000 United States dollar | superseded | [clm_F9BF9BBFB8B2](/claim/clm_F9BF9BBFB8B2.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_research_and_development | 47,000,000 United States dollar | superseded | [clm_6038DC9417B6](/claim/clm_6038DC9417B6.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 4,605,000,000 United States dollar | superseded | [clm_3C6AFF67BCF1](/claim/clm_3C6AFF67BCF1.md)
- 2024-09-30 to 2024-12-31 | money | total_assets | 56,175,000,000 United States dollar | superseded | [clm_E1C59296B7CC](/claim/clm_E1C59296B7CC.md)
- 2024-09-30 to 2024-12-31 | money | total_equity | 29,712,000,000 United States dollar | superseded | [clm_A03137CC10ED](/claim/clm_A03137CC10ED.md)
- 2024-10-17 to 2025-02-13 | money | shares_outstanding | 1,138,450,479 shares | superseded | [clm_B4A3EE8D8EBD](/claim/clm_B4A3EE8D8EBD.md)
- 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 3,619,000,000 United States dollar | superseded | [clm_AD1D43CA3EB1](/claim/clm_AD1D43CA3EB1.md)
- 2024-12-31 to 2025-12-31 | money | net_income | 3,348,000,000 United States dollar | superseded | [clm_000AB3D96DA6](/claim/clm_000AB3D96DA6.md)
- 2024-12-31 to 2025-12-31 | money | research_and_development | 197,000,000 United States dollar | superseded | [clm_51F4C2E26D8F](/claim/clm_51F4C2E26D8F.md)
- 2024-12-31 to 2025-12-31 | money | revenue | 18,682,000,000 United States dollar | superseded | [clm_128969DD8E17](/claim/clm_128969DD8E17.md)
- 2024-12-31 to 2025-03-31 | money | total_assets | 56,349,000,000 United States dollar | superseded | [clm_8A1B82586338](/claim/clm_8A1B82586338.md)
- 2024-12-31 to 2025-03-31 | money | total_equity | 29,928,000,000 United States dollar | superseded | [clm_4C81EC476BA0](/claim/clm_4C81EC476BA0.md)

## 2025

- 2025-02-13 to 2025-04-16 | money | shares_outstanding | 1,126,861,075 shares | superseded | [clm_4B7C103D5A58](/claim/clm_4B7C103D5A58.md)
- 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 4,698,000,000 United States dollar | superseded | [clm_88C570198E99](/claim/clm_88C570198E99.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 1,891,000,000 United States dollar | superseded | [clm_DDF438E4ED18](/claim/clm_DDF438E4ED18.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_research_and_development | 43,000,000 United States dollar | superseded | [clm_560762F7887F](/claim/clm_560762F7887F.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 5,010,000,000 United States dollar | superseded | [clm_4F70BE95B1F9](/claim/clm_4F70BE95B1F9.md)
- 2025-03-31 to 2025-06-30 | money | total_assets | 55,519,000,000 United States dollar | superseded | [clm_A4C85D97EB69](/claim/clm_A4C85D97EB69.md)
- 2025-03-31 to 2025-06-30 | money | total_equity | 31,248,000,000 United States dollar | superseded | [clm_904F0C77C8F5](/claim/clm_904F0C77C8F5.md)
- 2025-04-16 to 2025-07-17 | money | shares_outstanding | 1,112,996,934 shares | superseded | [clm_00DC935D0AF1](/claim/clm_00DC935D0AF1.md)
- 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 6,185,000,000 United States dollar | superseded | [clm_71EA01B49542](/claim/clm_71EA01B49542.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 2,061,000,000 United States dollar | superseded | [clm_E9AF3B618334](/claim/clm_E9AF3B618334.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_research_and_development | 40,000,000 United States dollar | superseded | [clm_3931BA9395E3](/claim/clm_3931BA9395E3.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 5,317,000,000 United States dollar | superseded | [clm_872F27D7544A](/claim/clm_872F27D7544A.md)
- 2025-06-30 to 2025-09-30 | money | total_assets | 55,165,000,000 United States dollar | superseded | [clm_C35731717100](/claim/clm_C35731717100.md)
- 2025-06-30 to 2025-09-30 | money | total_equity | 32,112,000,000 United States dollar | superseded | [clm_44E46A49D14C](/claim/clm_44E46A49D14C.md)
- 2025-07-17 to 2025-10-16 | money | shares_outstanding | 1,098,449,725 shares | superseded | [clm_EF52DAAC3DE2](/claim/clm_EF52DAAC3DE2.md)
- 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 5,639,000,000 United States dollar | superseded | [clm_4FEA899E8DA4](/claim/clm_4FEA899E8DA4.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 1,832,000,000 United States dollar | superseded | [clm_B59990B15056](/claim/clm_B59990B15056.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_research_and_development | 40,000,000 United States dollar | superseded | [clm_AA32A08F7523](/claim/clm_AA32A08F7523.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 5,524,000,000 United States dollar | superseded | [clm_E1D1822AC1BD](/claim/clm_E1D1822AC1BD.md)
- 2025-09-30 to 2025-12-31 | money | total_assets | 54,690,000,000 United States dollar | superseded | [clm_D561C13E6040](/claim/clm_D561C13E6040.md)
- 2025-09-30 to 2025-12-31 | money | total_equity | 33,226,000,000 United States dollar | superseded | [clm_307FD40CC7AC](/claim/clm_307FD40CC7AC.md)
- 2025-10-16 to 2026-02-12 | money | shares_outstanding | 1,091,262,981 shares | superseded | [clm_32F942FB6DBE](/claim/clm_32F942FB6DBE.md)
- 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 7,647,000,000 United States dollar | superseded | [clm_1D9735D5055A](/claim/clm_1D9735D5055A.md)
- 2025-12-31 | money | net_income | 7,085,000,000 United States dollar | valid | [clm_650595666B65](/claim/clm_650595666B65.md)
- 2025-12-31 | money | research_and_development | 166,000,000 United States dollar | valid | [clm_79F9154ED9D3](/claim/clm_79F9154ED9D3.md)
- 2025-12-31 | money | revenue | 22,669,000,000 United States dollar | valid | [clm_7B0466960195](/claim/clm_7B0466960195.md)
- 2025-12-31 to 2026-03-31 | money | total_assets | 57,121,000,000 United States dollar | superseded | [clm_7C27BF1C1694](/claim/clm_7C27BF1C1694.md)
- 2025-12-31 to 2026-03-31 | money | total_equity | 33,867,000,000 United States dollar | superseded | [clm_25A0CF64213F](/claim/clm_25A0CF64213F.md)

## 2026

- 2026-01-01 | people | ceo | Natascha Viljoen | valid | [clm_AA4656183438](/claim/clm_AA4656183438.md)
- 2026-02-12 to 2026-04-16 | money | shares_outstanding | 1,087,874,212 shares | superseded | [clm_9F69752BD33C](/claim/clm_9F69752BD33C.md)
- 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 8,775,000,000 United States dollar | superseded | [clm_E04B51781ECA](/claim/clm_E04B51781ECA.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 3,262,000,000 United States dollar | superseded | [clm_D6ADFE659BB2](/claim/clm_D6ADFE659BB2.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_research_and_development | 45,000,000 United States dollar | superseded | [clm_7A6857E2EB10](/claim/clm_7A6857E2EB10.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 7,307,000,000 United States dollar | superseded | [clm_A685141B98CA](/claim/clm_A685141B98CA.md)
- 2026-03-31 to 2026-06-30 | money | total_assets | 57,670,000,000 United States dollar | superseded | [clm_182E26248181](/claim/clm_182E26248181.md)
- 2026-03-31 to 2026-06-30 | money | total_equity | 34,926,000,000 United States dollar | superseded | [clm_BE2CCD294331](/claim/clm_BE2CCD294331.md)
- 2026-04-16 to 2026-07-16 | money | shares_outstanding | 1,067,552,764 shares | superseded | [clm_411AC6BFCBF0](/claim/clm_411AC6BFCBF0.md)
- 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 9,009,000,000 United States dollar | superseded | [clm_29BB6EF42D8B](/claim/clm_29BB6EF42D8B.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_net_income | 2,202,000,000 United States dollar | superseded | [clm_931C9FE0B2F4](/claim/clm_931C9FE0B2F4.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_research_and_development | 47,000,000 United States dollar | superseded | [clm_09B730DAA6D7](/claim/clm_09B730DAA6D7.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 6,118,000,000 United States dollar | superseded | [clm_CE4C3AE8650E](/claim/clm_CE4C3AE8650E.md)
- 2026-06-30 to 2026-09-30 | money | total_assets | 57,641,000,000 United States dollar | superseded | [clm_D00FDF27A92D](/claim/clm_D00FDF27A92D.md)
- 2026-06-30 to 2026-09-30 | money | total_equity | 35,243,000,000 United States dollar | superseded | [clm_9595BBF917F4](/claim/clm_9595BBF917F4.md)
- 2026-07-16 to 2026-10-15 | money | shares_outstanding | 1,053,692,271 shares | superseded | [clm_86E8BA013839](/claim/clm_86E8BA013839.md)
- 2026-09-30 | money | cash_and_equivalents | 8,827,000,000 United States dollar | valid | [clm_D3E30EC720B1](/claim/clm_D3E30EC720B1.md)
- 2026-09-30 | money | quarterly_net_income | 2,475,000,000 United States dollar | valid | [clm_AA15C80B4B3F](/claim/clm_AA15C80B4B3F.md)
- 2026-09-30 | money | quarterly_research_and_development | 58,000,000 United States dollar | valid | [clm_3C64E4DF9847](/claim/clm_3C64E4DF9847.md)
- 2026-09-30 | money | quarterly_revenue | 6,363,000,000 United States dollar | valid | [clm_AFF884E9A5F0](/claim/clm_AFF884E9A5F0.md)
- 2026-09-30 | money | total_assets | 58,183,000,000 United States dollar | valid | [clm_E7BC2C49CCB4](/claim/clm_E7BC2C49CCB4.md)
- 2026-09-30 | money | total_equity | 35,675,000,000 United States dollar | valid | [clm_45B5C3B3DC52](/claim/clm_45B5C3B3DC52.md)
- 2026-10-15 | money | shares_outstanding | 1,039,193,185 shares | valid | [clm_1C33ED92C7E4](/claim/clm_1C33ED92C7E4.md)

## undated

- undated | people | cfo | Peter Wexler | valid | [clm_40DFB0595960](/claim/clm_40DFB0595960.md)
- undated | people | chair | Gregory H. Boyce | valid | [clm_9A68F7C76FE7](/claim/clm_9A68F7C76FE7.md)
- undated | other | cik | 0001164727 | valid | [clm_8C8536BDC368](/claim/clm_8C8536BDC368.md)
- undated | other | fiscal_year_end | 12-31 | valid | [clm_F853FCCA658A](/claim/clm_F853FCCA658A.md)
- undated | other | headquarters | Denver | valid | [clm_9EB47735EF14](/claim/clm_9EB47735EF14.md)
- undated | other | listed_on | OTC | valid | [clm_09E6DB4E3BCD](/claim/clm_09E6DB4E3BCD.md)
- undated | other | listed_on | NYSE | valid | [clm_9D702A992CCE](/claim/clm_9D702A992CCE.md)
- undated | other | sic_industry | Gold and Silver Ores (1040) | valid | [clm_C7FAC0667C33](/claim/clm_C7FAC0667C33.md)
- undated | other | state_of_incorporation | DE | valid | [clm_707E8CDDE404](/claim/clm_707E8CDDE404.md)
- undated | other | ticker | NEMCL | valid | [clm_8301ACA6EE47](/claim/clm_8301ACA6EE47.md)
- undated | other | ticker | NEM | valid | [clm_95D49A36815D](/claim/clm_95D49A36815D.md)
- undated | other | website | http://www.newmont.com | unverified | [clm_E2E3605339D6](/claim/clm_E2E3605339D6.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.